Sexual health

Ergoloid: the research history.

Ergoloid is listed in the four-ingredient topical arousal cream. Its literature search includes the related term dihydroergotoxine, so the exact material named in each paper needs to stay visible.

253records matching the ingredient search
1connected formulations
6displayed publication records

How the research connects to the formula

An ingredient alias can help find older publications, but it can also broaden a search. The publication count therefore describes the stated search terms rather than a number of trials of this cream.

The other three catalog ingredients have separate literature histories. Looking at the cream as a network of ingredient records makes it possible to inspect that history without implying that every retrieved paper tested the combination.

Current HealthRX.com formulation map
ProductListed formulationConnected ingredient research
Prescription Arousal CreamAminophylline / Ergoloid / Pentoxifylline / SildenafilAminophylline · Ergoloid · Pentoxifylline · Sildenafil

Publication history

When the ingredient appeared in the literature

The chart counts records mentioning the search terms in their title or abstract. It includes research beyond sexual health. Use the period controls to inspect the count.

2026: 2 indexed publications. 2026 includes publications dated through October 5. The earlier bars cover longer periods than the annual bars.

View the chart as a data table
PeriodPublications
1900-19590
1960-19694
1970-197949
1980-1989137
1990-199932
2000-200913
2010-20144
2015-20194
20200
20211
20221
20231
20243
20252
20262
Search query and data source

Source: Europe PMC’s PubMed-indexed records. Retrieved October 5, 2026. The index’s firstPublicationDate field supplies the dates and chart periods; it can normalize a month-only record to the first day of the month. Dates through October 5 are included. Counts can change as the index adds or corrects records.

TITLE_ABS:((ergoloid OR "dihydroergotoxine")) AND SRC:MED AND FIRST_PDATE:[1900-01-01 TO 2026-10-05]

Open this literature search · Download the data

A closer search for this product question

The focused search returns 1 publications. It narrows the ingredient query to terms connected with its catalog use. Its displayed records remain a search sample, not a ranking of study quality.

View the focused query

TITLE_ABS:((ergoloid OR "dihydroergotoxine")) AND TITLE_ABS:((sexual OR arousal)) AND SRC:MED AND FIRST_PDATE:[1900-01-01 TO 2026-10-05]

Open the focused search

Dated publications

Read individual records in context

The timeline combines selected references with a sample from the ingredient search. Dates use the index’s firstPublicationDate field; the PubMed record may distinguish an earlier online date from the print date. Written study notes appear alongside the records that have them. Other entries show the indexed bibliography and link to the paper.

Research Support, Non-U.S. Gov't · Journal Article

Autoradiographic localization of the dopaminergic agonist 3H-dihydroergotoxine within the male reproductive system.

Amenta D, Cavallotti C, De Rossi M, Ferrante F, Amenta F. Functional neurology. PMID 3666550.

This record identifies a publication and its indexed publication types. The full paper contains the study methods, population, formulation and results.

Read the PubMed record

Questions that shape the comparison

Does the publication identify the same ergoloid preparation? Does it examine the topical route and the intended subject of the product?

Source records

Autoradiographic localization of the dopaminergic agonist 3H-dihydroergotoxine within the male reproductive system.Amenta D, Cavallotti C, De Rossi M, Ferrante F, Amenta F.Functional neurology. 1987-04-01. PMID 3666550. Research Support, Non-U.S. Gov't, Journal Article.
Attenuation of Type IV pili activity by natural products.Yalkut K, Ben Ali Hassine S, Basaran E, Kula C, Ozcan A, Avci FG, Keskin O, Sariyar Akbulut B, Ozbek P.Journal of biomolecular structure & dynamics. 2024-02-02. PMID 38305801. Journal Article.
Mid-long term efficacy of dihydroergotoxine mesylate in treatment of sialorrhea in Parkinson's disease.Jin H, Huang T, Wu J, Zhu Y, Gao Q, Tian Y.Clinical neurology and neurosurgery. 2025-11-11. PMID 41237588. Research Support, Non-U.S. Gov't, Journal Article.
"Comment on: Mid-long term efficacy of dihydroergotoxine mesylate in treatment of sialorrhea in Parkinson's disease".Noor G, Kabir A, Hemani AH.Clinical neurology and neurosurgery. 2026-03-18. PMID 41863888. Letter.

Research data assembled by HealthRX.com from the displayed source records, October 5, 2026. The atlas contains a dated literature search and selected studies; it is not an exhaustive systematic review.